Phase 2b Study of ALTO-100 in MDD
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Adam Savitz, MD, PhD
Alto Neuroscience
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
34 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Site 174
Birmingham, Alabama, United States
- Site 173
Huntsville, Alabama, United States
- Site 136
Chandler, Arizona, United States
- Site 139
Little Rock, Arkansas, United States
- Site 141
Costa Mesa, California, United States
- Site 118
Fresno, California, United States
- Site 181
Imperial, California, United States
- Site 182
Oceanside, California, United States
- Site 188
Oceanside, California, United States
- Site 179
Rancho Cucamonga, California, United States
- Site 116
Sacramento, California, United States
- Site 185
Centennial, Colorado, United States
- Site 186
Brooksville, Florida, United States
- Site 204
Jacksonville, Florida, United States
- Site 205
Orlando, Florida, United States
- Site 212
Tampa, Florida, United States
- Site 213
Tampa, Florida, United States
- Site 137
Carmel, Indiana, United States
- Site 151
Baltimore, Maryland, United States
- Site 108
Jackson, Mississippi, United States
- Site 171
Jackson, Mississippi, United States
- Site 142
Lincoln, Nebraska, United States
- Site 144
Las Vegas, Nevada, United States
- Site 178
Albuquerque, New Mexico, United States
- Site 184
Brooklyn, New York, United States
- Site 180
New York, New York, United States
- Site 210
New York, New York, United States
- Site 175
Westlake, Ohio, United States
- Site 157
North Charleston, South Carolina, United States
- Site 183
Memphis, Tennessee, United States
- Site 147
Fort Worth, Texas, United States
- Site 120
Houston, Texas, United States
- Site 172
Houston, Texas, United States
- Site 121
Draper, Utah, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 10 Jan 2023
- Primary completion
- 5 Sept 2024
- Completion
- 24 Oct 2024
- Last update posted
- 8 Sept 2025
- Registered enrollment
- 301
- Registry id
- NCT05712187
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.